ADVERTISEMENT

Dr. Reddy’s Labs - Robust Show In FY23; But Outlook Subdued: Motilal Oswal

Moderation in earnings and valuations factored in.

<div class="paragraphs"><p>Dr. Reddys Laboratories R&amp;D centre (Source: Company website)</p></div>
Dr. Reddys Laboratories R&D centre (Source: Company website)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit